How to use this pathway
The HPV primary screening and follow-up pathway is a centralized hub for resources, evidence and real-world considerations to help provincial and territorial health systems and cancer screening partners implement human papillomavirus (HPV) primary screening and follow-up. The pathway contains six steps, each outlining leading national and international practices and resources (including considerations for partner engagement) that can enable equitable screening and embed cultural competency in healthcare teams. Learn more about how HPV primary screening and follow-up is critical to preventing cervical cancer.
Read recommendations for engaging with partners and local communities about HPV primary screening and follow-up.
Find out how to improve provider and participant awareness and education on HPV primary screening.
Alignment across strategies
The HPV Pathway reflects key priorities of the Canadian Strategy for Cancer Control and the Action Plan for the Elimination of Cervical Cancer in Canada, 2020-2030.
Guidelines to support follow-up after a positive HPV test
To support jurisdictions, the Partnership has funded the Society of Gynecologic Oncology of Canada (GOC) to develop clinical guidelines on the management of participants with a positive HPV test and risk-based colposcopy and surveillance, with collaboration from the Society of Canadian Colposcopists (SCC). GOC guidelines are not intended to supersede local guidance. Once released, a link to the guidelines will be available here.
Intended users of the pathway
The pathway was created to support provincial and territorial decision-makers and leaders responsible for the delivery of organized cervical cancer screening and follow-up care as they plan for the implementation of HPV primary screening and follow-up within their jurisdiction. This includes:
- provincial/territorial cancer agencies and screening programs
- provincial/territorial ministries, departments or branches responsible for cancer screening and control
- provincial/territorial laboratory service departments or branches
- research, practice and policy specialists working in cancer prevention, cancer screening, public health, cervical cancer treatment and Indigenous health, including professional organizations, community organizations and pan-Canadian health organizations
While care providers (including primary care, colposcopists and oncologists) are not the primary users of the pathway, they may find its content of use and important to consider as HPV primary screening is integrated in their practice.
Contributors to the pathway
The Partnership would like to thank and acknowledge the members of the HPV Screening and Abnormal Screen Follow-up Working Group, including the patient and family advisors, and representatives in primary care, cytology, colposcopy, who provided strategic guidance and expertise to the development of this pathway.
The Partnership would also like to thank the pan-Canadian Cervical Screening Network (PCCSN) and the Canadian Agency for Drugs and Technologies in Canada (CADTH) for input and resources shared to support the development of the pathway.